Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 2/2013

01-03-2013 | Brief Communication

Development of a Korean version of the Cancer Therapy Satisfaction Questionnaire (CTSQ): cross-cultural adaptation, reliability, and validity

Auteurs: So Jeong Park, Soo Min An, Se Hyun Kim

Gepubliceerd in: Quality of Life Research | Uitgave 2/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

(1) To translate original English Cancer Therapy Satisfaction Questionnaire (CTSQ) into Korean and perform validation, (2) to compare CTSQ domains of expectations of therapy (ET), feelings about side effects (FSE), and satisfaction with therapy (SWT) by cancer therapy type.

Methods

Cross-cultural adaptation was performed according to guidelines: translation, back translation, focus-group, and field test. We performed validation with internal consistency by Cronbach’s alpha and construct validity by exploratory factor analysis (EFA) with varimax rotation method. We compared each CTSQ domain between traditional Korean Medicine (TKM) and integrative cancer therapy (ICT) of combining western and TKM by two-sample t test.

Results

Cross-cultural adaptation produced no major modifications in the items and domains. A total of 102 outpatients were participated. Mean age was 51.9 ± 12.4. Most were stage 4 (74.4 %) cancer. Mean scores of ET, FSE, and SWT were 81.2 ± 15.7, 79.5 ± 22.9, and 75.7 ± 14.8, respectively. Cronbach’s alpha of ET, FSE, and SWT were 0.86, 0.78, and 0.74, respectively. EFA loaded items on the three domains, which is very close to that of the original CTSQ. ET and SWT was similar, but FSE was significantly higher in TKM than ICT (87.5 ± 19.3 vs. 74.9 ± 23.5; p = 0.0054).

Conclusions

Cross-cultural adaptation was successful, and the adapted Korean CTSQ demonstrated good internal consistency and construct validity. Similar expectation and satisfaction was shown between the two types of therapy, but patient’s reported feelings about side effects was significantly lower in patients receiving TKM than receiving ICT. Korean version of CTSQ can be used to evaluate Korean cancer patient’s experiences receiving various cancer therapy types.
vorige artikel Translation and validation of the Dutch version of the Effective Consumer Scale (EC-17)
volgende artikel A qualitative investigation of visual tasks with which to assess distance-specific visual function
Literatuur
1.
Trask, P., Tellefsen, C., Espindle, D., et al. (2008). Psychometric validation of the Cancer Therapy Satisfaction Questionnaire. Value in Health, 11(4), 669–679.PubMedCrossRef
2.
Speight, J. (2005). Assessing patient satisfaction: Concepts, applications, and measurement. Value in Health, 8S(1), S6–S8.CrossRef
3.
Wiggers, J. H., Donovan, K. O., Esdman, S., & Sanson-Fisher, R. W. (1990). Cancer patient satisfaction with care. Cancer, 66, 610–616.PubMedCrossRef
4.
Abetz, L., Coombs, J., Keininger, D., et al. (2005). Development of the Cancer Therapy Satisfaction Questionnaire: Item generation and content validity testing. Value in Health, 8(S1), S41–S53.PubMedCrossRef
5.
Fayers, P., Aaronson, N., Bjordal, K., On behalf of the EORTC Quality of Life Study Group, et al. (1999). EORTC QLQ-C30 scoring manual (2nd ed.). Brussels: EORTC Quality of Life Group.
6.
Atkinson, M. J., Sinha, A., Haas, S. I., et al. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Quality of Life Outcomes, 2, 12.CrossRef
7.
Hatcher, L. (1994). A step-by-step approach to using the SAS ® system for factor analysis and structural equation modeling. Cary, NC: SAS Institute, Inc.
8.
Greene, F. L., Page, D. L., Fleming, I. D., Fritz, A., Balch, C. M., Haller, D. G., et al. (2002). AJCC cancer staging manual (6th ed.). New York, NY, USA: Springer.
9.
Fritz, A., Percy, C., Jack, A., Shanmugarathan, S., Sobin, L., Parkin, D. M., et al. (2000). International classification of diseases for oncology (ICD-O) (3rd ed.). Geneva, Switzerland: World Health Organization.
10.
Fayers, P., & Machin, D. (2001). Quality of life: Assessment, analysis and interpretation. New York, NY, USA: Wiley.
11.
Choi, W. C., Lee, J. H., Lee, E. O., et al. (2006). Study on antiangiogenic and antitumor activities of processed Rhus verniciflua Stokes extract. Korean Journal of Oriental Physiology & Pathology, 20, 1–5.
12.
Choi, W. C., Sminova, Z., Kubasova, I., et al. (2002). Antitumor efficacy of the allergen removed extract in Rhus verniciflua. European Journal of Pharmaceutical Sciences, 17S, S78–S79.
13.
Lee, S. H., Choi, W. C., & Yoon, S. W. (2009). Impact of standardized Rhus verniciflua Stokes extract as complementary therapy on metastatic colorectal cancer: A Korean single-center experience. Integrative Cancer Therapies, 8, 148–152.PubMedCrossRef
14.
Lee, S. H., Kim, K. S., Choi, W. C., & Yoon, S. W. (2009). Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua Stokes extract: A case study. Explore, 5, 242–244.PubMedCrossRef
15.
De Vaus, D. (2002). Surveys in social research (5th ed.). Sydney: Allen & Unwin.
16.
Nunnally, J., & Bernstein, I. (1994). The assessment of reliability. Psychometric theory. New York: McGraw-Hill.
17.
Chassany, O., Sagnier, P., & Marquis, P. (2002). Patient-reported outcomes: The example of health-related quality of life—A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209–238.CrossRef
18.
Andresen, E. M. (2000). Criteria for assessing the tools of disability outcomes research. Archives of Physical Medicine and Rehabilitation, 81(12 Suppl 2), S15–S20.PubMedCrossRef
19.
Fitzpatrick, R., Davey, C., Buxton, M. J., & Jones, D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2(14):i–iv, 1–74.
20.
Portney, L., Watkins, M., et al. (2000). Foundations of clinical research: Applications to practice. Upper Saddle River, NJ: Prentice Hall.
Metagegevens
Titel
Development of a Korean version of the Cancer Therapy Satisfaction Questionnaire (CTSQ): cross-cultural adaptation, reliability, and validity
Auteurs
So Jeong Park
Soo Min An
Se Hyun Kim
Publicatiedatum
01-03-2013
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 2/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-012-0164-0

Andere artikelen Uitgave 2/2013

Quality of Life Research 2/2013 Naar de uitgave

OriginalPaper

Psychological comorbidity in patients with chronic tinnitus: analysis and comparison with chronic pain, asthma or atopic dermatitis patients

OriginalPaper

Further validation of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) in the UK veterinary profession: Rasch analysis

OriginalPaper

A qualitative investigation of visual tasks with which to assess distance-specific visual function

Brief Communication

Feasibility, reliability and validity of the Thai version of the Pediatric Quality of Life Inventory 3.0 cerebral palsy module

Brief Communication

Health Utilities Index Mark 3 (HUI3) demonstrated construct validity in a Nigerian population with hypertension

OriginalPaper

Physical activity, self-efficacy, and health-related quality of life in persons with multiple sclerosis: analysis of associations between individual-level changes over one year